Principal Investigator
Sara Wester
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230246
Clinical Trial Summary
IMVT-1401-3201: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other